Autologous Stem Cell Therapy in Patients With Multiple System Atrophy

Summary

This study investigates the safety and efficacy of autologous stem cell therapy in patients with Multiple System Atrophy (MSA), a rare and progressive neurodegenerative disorder characterized by autonomic failure, parkinsonism, and cerebellar ataxia. The trial will evaluate functional outcomes, motor performance, and quality of life compared to placebo/controlled group.

Timeline

Start

2026-09-01

Primary completion

2029-09-01

Completion

2031-03-01

Drugs

Indications